SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
The Five Best Life Science Companies with Great Perks and Work Culture
Biotech Bay
The 5 Best Life Science Companies with Great Perks and Work Culture
April 6, 2016
 · 
8 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Janssen Research & Development, Genentech Forge Clinical Trials Agreement
March 22, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Policy
Genentech’s Bladder Cancer Drug Gains Priority Review by the FDA
March 15, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Amid Fierce Competition from GlaxoSmithKline, AstraZeneca PLC and Teva, Two of Genentech’s Asthma Drug Trials Disappoint
February 29, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Policy
Nine Cancer Centers Accuse Genentech of Shipping Less Herceptin than Promised
February 24, 2016
 · 
2 min read
Biopharma Business Grad Hiring Is Up, with Johnson & Johnson, Eli Lilly and Bayer and Genentech Leading the Way
Job Trends
Biopharma Business Grad Hiring Is Up, with Johnson & Johnson, Eli Lilly, Bayer and Genentech Leading the Way
January 25, 2016
 · 
3 min read
Job Trends
Denali, Helmed by Former Genentech Execs, Takes Space in South San Francisco Site
January 18, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Exelixis, Genentech’s Cobimetinib Succeeds in Pivotal Phase III Trial
October 6, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Arvinas Inks $300 Million Deal With Genentech Over Protein Degradation Technology
October 1, 2015
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
BioMidwest
Genentech Named Founding Partner For Pulmonary Fibrosis Foundation Patient Registry Program
November 5, 2015
 · 
3 min read
Drug Development
Xenon Pharmaceuticals Inc. Announces Its Partner Genentech Has Advanced GDC-0310, A Second Nav1.7 Inhibitor For Pain, Into Clinical Development
October 22, 2015
 · 
4 min read
Business
Nimbus Therapeutics Scores a Global License Agreement with Genentech, Financial Terms Undisclosed
October 20, 2015
 · 
2 min read
Drug Development
Genentech’s Ocrelizumab First Investigational Medicine To Show Positive Pivotal Study Results In Both Relapsing And Primary Progressive Forms Of Multiple Sclerosis
October 8, 2015
 · 
11 min read
Drug Development
Two Positive Studies Of Genentech’s Investigational Cancer Immunotherapy Atezolizumab In Specific Type Of Lung Cancer Presented At 2015 European Cancer Congress
September 28, 2015
 · 
1 min read
Drug Development
Genentech’s New Drug Shows Benefits in Phase II Lung, Bladder Cancer Tests
September 28, 2015
 · 
7 min read
Business
Xenon Pharmaceuticals Inc. Achieves Milestone In Genentech Collaboration To Discover Novel Pain Targets
September 21, 2015
 · 
4 min read
Drug Development
FDA Grants Genentech’s Alectinib Priority Review For Specific Type Of ALK-Positive Lung Cancer
September 9, 2015
 · 
5 min read
Drug Development
Genentech’s Alectinib Granted Priority Review by the FDA
September 9, 2015
 · 
6 min read
Drug Development
FDA Grants Breakthrough Therapy Designation For Genentech’s Investigational Medicine ACE910 for People With Hemophilia A With Factor VIII Inhibitors
September 4, 2015
 · 
4 min read
Load More